BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

De Novo Pharmaceuticals Ltd

The volume of structural protein data that will emerge in the next few years will serve as a driver that transforms the pharmaceutical industry. Over the next decade it is predicted that the high-resolution 3-D structure of all proteins that precisely define the biological space of human, pathogenic organisms and plant proteomes will be available. As this flood of data on proteins becomes available, De Novo is centrally positioned to efficiently link biological space to chemical space.


Contact Details:
Compass HouseVision ParkHiston
Cambridge
Cambridgeshire
CB4 9ZR
United Kingdom
Tel:44 (0)1223 238000
Fax:
Email:info@denovopharma.com
WWW:

www.denovopharma.com/




Recent Publications by De Novo Pharmaceuticals Ltd:

De novo ligand design to partially flexible active sites: application of the ReFlex algorithm to carboxypeptidase A, acetylcholinesterase, and the estrogen receptor.
Reflex is a recent algorithm in the de novo ligand design software,...
6th May, 2008
De Novo Pharmaceuticals Ltd., Compass House, Vision Park, Chivers Way, J Chem Inf Model. 2008 Feb;48(2):296-305. Epub 2008 Jan 31.
DOI Direct Link
Chemical genomics: a challenge for de novo drug design.
De novo design provides an in silico toolkit for the design of novel small...
12th January, 2008
De Novo Pharmaceuticals Ltd., Vision Park, Compass House, Histon, Mol Biotechnol. 2007 Nov;37(3):237-45. Epub 2007 Jun 30.
DOI Direct Link
Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen.
A de novo design approach to generating novel estrogen receptor (ER)...
9th September, 2006
De Novo Pharmaceuticals Ltd., Compass House, Vision Park, Histon, J Chem Inf Model. 2006 Mar-Apr;46(2):642-7.
DOI Direct Link
De novo ligand design to an ensemble of protein structures.
We describe a combinatorial method for de novo ligand design to an...
10th August, 2006
De Novo Pharmaceuticals Ltd., Compass House, Cambridge, United Kingdom. Proteins. 2006 Jul 1;64(1):43-59.
DOI Direct Link
Exhaustive de novo design of low-molecular-weight fragments against the ATP-binding site of DNA-gyrase.
We present a de novo design approach to generating small fragments in the...
29th June, 2006
De Novo Pharmaceuticals Ltd., Compass House, Vision Park, Histon, J Chem Inf Model. 2006 May-Jun;46(3):1168-73.
DOI Direct Link

View more De Novo Pharmaceuticals Ltd research publications.

BioNews Results for De Novo Pharmaceuticals Ltd:

STOCKS NEWS EUROPE-Novo shares fall on news of Byetta woes
Sharewatch:  Aug 27 2008 10:03AM Matching: de novo pharmaceuticals
Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R)
SmartBrief:  Aug 21 2008 8:37AM Matching: de novo pharmaceuticals
ADR REPORT: Financial Sector, European Market Drag Stocks
Lloyd's:  Aug 20 2008 11:07AM Matching: de novo pharmaceuticals
Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R)
Cincinnati Business Journal:  Aug 19 2008 12:42PM Matching: de novo pharmaceuticals
Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R)
Business Journal of Milwaukee:  Aug 19 2008 12:41PM Matching: de novo pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more De Novo Pharmaceuticals Ltd news.

De Novo Pharmaceuticals Ltd Patents:

US Patent No.Title
7323596 Antimicrobial agents
7241921 Bacterial enzyme inhibitors

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 157 times since April 2007, the link to the organisation's website has been followed 35 times

Recent Search Terms used to find this page: De Novo Pharmaceuticals Ltd | .

Search for more companies in Cambridge

Search for more companies in Cambridgeshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for De Novo Pharmaceuticals Ltd
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.